According to Mars Finance, on November 7, Canadian biopharmaceutical company Quantum BioPharma Ltd. (QNTM) stated in its third quarter financial and operational performance that year-to-date, the company has achieved a profit of $572,000 from its digital asset portfolio primarily composed of Bitcoin.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Quantum BioPharma's digital asset portfolio has achieved a profit of $572,000 year-to-date.
According to Mars Finance, on November 7, Canadian biopharmaceutical company Quantum BioPharma Ltd. (QNTM) stated in its third quarter financial and operational performance that year-to-date, the company has achieved a profit of $572,000 from its digital asset portfolio primarily composed of Bitcoin.